<DOC>
	<DOC>NCT01879137</DOC>
	<brief_summary>the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.</brief_summary>
	<brief_title>Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polyuria</mesh_term>
	<mesh_term>Polydipsia</mesh_term>
	<mesh_term>Diabetes Insipidus</mesh_term>
	<criteria>1. Age over 18 years 2. No medication except hormonal contraception 1. Evidence of any acute illness 2. Subjects refusing or unable to give written informed consent 3. Pregnancy 4. Any evidence of disordered drinking habits and diuresis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Copeptin</keyword>
	<keyword>Arginin stimulation test</keyword>
</DOC>